来自结构性和功能性基因组学的伯基特淋巴瘤病原和治疗点
Roland Schmitz1, Ryan M Young, Michele Ceribelli
1Metabolism Branch Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland 20892, USA.
Nature
|August 14, 2012
概括
新的研究揭示了驱动伯基特淋巴瘤 (BL) 的关键遗传途径. 了解这些机制,包括TCF3和CCND3突变,为BL患者开发少毒性疗法提供了希望.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 伯基特淋巴瘤 (BL) 是一种B细胞癌症,通常用化疗治疗,但治疗毒性限制了其在某些人群中的使用.
- BL和扩散性大B细胞淋巴瘤 (DLBCL) 的起源细胞是生殖中心B细胞,但它们的致癌途径可能不同.
- BL的亚型 (偶发性,特有性,与艾滋病毒相关) 可能利用不同的致癌机制.
研究的目的:
- 为了确定与MYC合作的关键调节途径,在伯基特淋巴瘤中.
- 调查特定基因突变在BL病变发生中的作用.
- 为了发现BL的潜在治疗点.
主要方法:
- 使用高通量RNA测序来分析BL中的基因表达.
- 用RNA干扰查来确定关键的调节通路.
- 基因分析的重点是TCF3,ID3和CCND3.3中的突变.
主要成果:
- 在70%的零星BL病例中发现了TCF3或其调节器ID3的突变,导致TCF3依赖.
- 观察到TCF3激活酸-3-OH激酶通路,部分通过B细胞受体信号传递.
- 在38%的零星BL病例中发现了致癌CCND3突变,产生稳定的环素D3异型,推动细胞周期进展.
结论:
- 在TCF3/ID3和CCND3中的特定突变是零星BL的关键驱动因素.
- 这些发现突显了BL中独特的瘤性途径.
- 已识别的途径为BL的新,少有毒的治疗策略提供了潜在的目标.
更多相关视频
09:37Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
07:21Molecular and Immunologic Techniques in a Genetically Engineered Mouse Model of Gastrointestinal Stromal Tumor
Published on: May 2, 2022
相关概念视频
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Healing II: Complications
Complications during healing arise when tissue repair is altered by local or systemic factors. These changes involve abnormal collagen deposition, altered biomechanics, and reduced vascular supply, impairing restoration of normal structure and function.Loss of FunctionScar tissue differs significantly from the original tissue it replaces. In the skin, fibrosis lacks adnexal structures such as hair follicles, sebaceous glands, and sweat glands. Their absence reduces tactile sensitivity, impairs...
